Blood Biomarkers Predict Survival Outcomes in Patients with Hepatitis B Virus-Induced Hepatocellular Carcinoma Treated with PD-1 Inhibitors

Table 3

Multivariate Cox proportional hazards regression models for progression-free survival.

Variable	Multivariate analysis
	HR	95% CI	value
Child-Pugh class
B vs. A	0.799	0.185-3.453	0.764
CNLC stage
IIIb vs. IIb and IIIa	3.986	0.803-19.774	0.901
AFP
≥400 vs. <400 ng/ml	1.935	0.697-5.376	0.205
PVTT
Yes vs. none	8.189	1.027-65.288	0.047
SII
≥970 vs. <970	7.112	2.373-21.314	<0.0001